University of Cape Coast Institutional Repository

APOBEC3G expression and HIV-1 infection in Burkina Faso

Show simple item record

dc.contributor.author Compaor, Tegwinde Rebeca
dc.contributor.author Soubeiga, Serge Theophile
dc.contributor.author Ouattara, Abdoul Karim
dc.contributor.author Tchelougou, Damehan
dc.contributor.author Bisseye, Cyrille
dc.contributor.author Bakouan, Didier Romuald
dc.contributor.author Compaore, Issaka
dc.contributor.author Dembele, Augustine
dc.contributor.author Yonli, Albert Theophane
dc.contributor.author Obiri-Yeboah, Dorcas
dc.contributor.author Djigma, Wendkuuni Florencia
dc.contributor.author Simpore, Jacques
dc.date.accessioned 2023-10-17T14:50:39Z
dc.date.available 2023-10-17T14:50:39Z
dc.date.issued 2018
dc.identifier.uri http://hdl.handle.net/123456789/9560
dc.description.abstract APOBEC3G is a potent inhibitor of HIV-1 replication, and act by deaminating cytidines in uracil on the negative strand of the viral cDNA. In this case-control study, APOBEC3G expression in subjects’ naïve to HAART infected by HIV-1 and the effect of APOBEC3G polymorphism on its expression were evaluated. The results show that the HIV-1 infected carriers of the G minor alleles of the variant rs8177832 had a higher expression of APOBEC3G mRNA than the controls carriers of the G minor allele. APOBEC3G polymorphisms could play an important role in the modulation of the HIV-1 dissemination en_US
dc.language.iso en en_US
dc.publisher Journal of Public Health in Africa en_US
dc.subject HIV-1 en_US
dc.subject APOBEC3G mRNA en_US
dc.subject rs8177832 en_US
dc.subject rs35228531 en_US
dc.subject rs6001417 en_US
dc.subject Burkina Faso. en_US
dc.title APOBEC3G expression and HIV-1 infection in Burkina Faso en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UCC IR


Advanced Search

Browse

My Account